Portal de Periódicos da CAPES

Increased expression of CIP 2 A in aggressive subtypes of B ‐cell lymphoma

2013; Wiley; Volume: 63; Issue: 3 Linguagem: Inglês

10.1111/his.12162

1365-2559

Laura Lilja, Kirsi‐Maria Haapasaari, Risto Bloigu, Tarja Salonen, Ari Ristimäki, Taina Turpeenniemi‐Hujanen, Outi Kuittinen,

RNA modifications and cancer

HistopathologyVolume 63, Issue 3 p. 438-439 Correspondence Increased expression of CIP2A in aggressive subtypes of B-cell lymphoma Laura Lilja, Laura Lilja Department of Oncology and Radiotherapy, Oulu University Hospital, University of Oulu, Oulu, FinlandSearch for more papers by this authorKirsi-Maria Haapasaari, Kirsi-Maria Haapasaari Departments of Pathology and Oncology, Oulu University Hospital, Oulu, FinlandSearch for more papers by this authorRisto Bloigu, Risto Bloigu University of Oulu, Oulu, FinlandSearch for more papers by this authorTarja Salonen, Tarja Salonen Laboratory of Pathology and Genetics, Joint Authority of Helsinki and Uusimaa HUSLAB, Helsinki, FinlandSearch for more papers by this authorAri Ristimäki, Ari Ristimäki Department of Pathology, HUSLAB and Haartman Institute, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland Research Program Unit, Genome-Scale Biology, University of Helsinki, Helsinki, FinlandSearch for more papers by this authorTaina Turpeenniemi-Hujanen, Taina Turpeenniemi-Hujanen Department of Oncology and Radiotherapy, Oulu University Hospital, University of Oulu, Oulu, FinlandSearch for more papers by this authorOuti Kuittinen, Outi Kuittinen Department of Oncology and Radiotherapy, Oulu University Hospital, University of Oulu, Oulu, FinlandSearch for more papers by this author Laura Lilja, Laura Lilja Department of Oncology and Radiotherapy, Oulu University Hospital, University of Oulu, Oulu, FinlandSearch for more papers by this authorKirsi-Maria Haapasaari, Kirsi-Maria Haapasaari Departments of Pathology and Oncology, Oulu University Hospital, Oulu, FinlandSearch for more papers by this authorRisto Bloigu, Risto Bloigu University of Oulu, Oulu, FinlandSearch for more papers by this authorTarja Salonen, Tarja Salonen Laboratory of Pathology and Genetics, Joint Authority of Helsinki and Uusimaa HUSLAB, Helsinki, FinlandSearch for more papers by this authorAri Ristimäki, Ari Ristimäki Department of Pathology, HUSLAB and Haartman Institute, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland Research Program Unit, Genome-Scale Biology, University of Helsinki, Helsinki, FinlandSearch for more papers by this authorTaina Turpeenniemi-Hujanen, Taina Turpeenniemi-Hujanen Department of Oncology and Radiotherapy, Oulu University Hospital, University of Oulu, Oulu, FinlandSearch for more papers by this authorOuti Kuittinen, Outi Kuittinen Department of Oncology and Radiotherapy, Oulu University Hospital, University of Oulu, Oulu, FinlandSearch for more papers by this author First published: 17 April 2013 https://doi.org/10.1111/his.12162Citations: 8Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. References 1Junttila MR, Puustinen P, Niemelä M et al. CIP2A inhibits PP2A in human malignancies. Cell 2007; 130; 51– 62. 2Junttila MR, Westermarck J. Mechanisms of MYC stabilization in human malignancies. Cell Cycle 2008; 7; 592– 596. 3Khanna A, Bockelman C, Hemmes A et al. MYC-dependent regulation and prognostic role of CIP2A in gastric cancer. J. Natl Cancer Inst. 2009; 101; 793– 805. 4Bockelman C, Hagstrom J, Makinen LK et al. High CIP2A immunoreactivity is an independent prognostic indicator in early-stage tongue cancer. Br. J. Cancer 2011; 104; 1890– 1895. 5Bockelman C, Koskensalo S, Hagstrom J, Lundin M, Ristimaki A, Haglund C. CIP2A overexpression is associated with c-Myc expression in colorectal cancer. Cancer Biol. Ther. 2012; 13; 289– 295. 6Bockelman C, Lassus H, Hemmes A et al. Prognostic role of CIP2A expression in serous ovarian cancer. Br. J. Cancer 2011; 105; 989– 995. Citing Literature Volume63, Issue3September 2013Pages 438-439 ReferencesRelatedInformation